MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    Refractory Orthostatic Hypotension, Anterocollis Predominant Cervical Dystonia and Parkinsonism Associated with a Previously Undiscovered SYT14 Gene Mutation

    W. Gan, O. Carranza-Renteria, T. Fistel, S. Husain-Wilson (Boca Raton, USA)

    Objective: We present a case of a patient with spinocerebellar ataxia symptoms associated with a previously unknown mutation of the SYT14 gene. Background: Spinocerebellar ataxias…
  • 2025 International Congress

    Engage- Qatar PD: The development of an online self-management intervention to promote engagement in physical activity for people with PD in Qatar

    H. Khalil, R. Hammad, M. Rawash, S. Pedersen, L. Morris, M. Choudhury, L. Quinn, A. Oun (Doha, Qatar)

    Objective: To develop the Engage-Qatar PD self-management intervention with cultural-adaptations for people with PD in Qatar. Background: Many people with PD engage in insufficient exercise…
  • 2025 International Congress

    The Moroccan LRRK2 Registry: Building Resources to Investigate the Penetrance and Phenotype of LRRK2 in North Africans

    Y. Razouqi, M. Megraoui, F. Belahsen, L. Bouguenouch, B. Elmakhzen, H. Ouhabi, J. Aasfara, Y. Zaid, A. Atpu, L. Khalki, M. Rizig (Casablanca, Morocco)

    Objective: The Moroccan LRRK2 Registry aims to establish a comprehensive database integrating clinical data and biosamples to provide valuable insights into the penetrance, phenotype, and…
  • 2025 International Congress

    Superior cluneal neuralgia in Parkinson’s disease: frequency and clinical features.

    M. Mihara, Y. Kajiyama, A. Saito, R. Satake, Y. Kutoku (Kurashiki, Japan)

    Objective: We investigated the frequency and clinical characteristics of superior cluneal neuralgia (SCN) in patients with Parkinson's disease (PD). Background: The superior cluneal nerve is…
  • 2025 International Congress

    Uncovering the heterogeneity of spatiotemporal trajectories of neurodegeneration in Parkinson’s disease: an early-phase 18F-FP-CIT PET study

    SJ. Chung, J. Lee, Y. Choi, J. Jang, HK. Na, PH. Lee (Seoul, Republic of Korea)

    Objective: To define the subtypes of Parkinson’s disease (PD) based on the spatiotemporal progression patterns of cerebral hypoperfusion. Background: Early-phase 18F-FP-CIT PET images, which are…
  • 2025 International Congress

    Effectiveness of Tele-Education Programs in Improving Knowledge of Movement Disorders among Medical Students in Different Economic Settings

    H. Elkasaby, F. Abdelbar, M. Badran, M. Mohamed, A. Nagah, Z. Hegazy, K. Ahmed, M. M.ELSAYED (Giza, Egypt)

    Objective: To assess the effectiveness of tele-education programs in enhancing medical students' knowledge of movement disorders across different economic settings and identify key factors influencing…
  • 2025 International Congress

    Quantifying Bradykinesia in Real-world Practice: A Clinician-friendly Video Analysis Tool for Parkinson’s Disease

    Z. Xu, Y. Tang, J. Wang (Shanghai, China)

    Objective: To develop and validate a video-based automated analysis tool for the objective and quantitive assessment of bradykinesia in Parkinson’s disease (PD). Background: Currently, evaluating…
  • 2025 International Congress

    HPRT1 Gene Mutation in a Young Male with Early Childhood Onset Seizures-Parkinsonism and Levodopa-Induced Dyskinesia: A Case Report

    A. Mansour, A. Kilany (Cairo, Egypt)

    Objective: To report the clinical course, diagnostic evaluation, and genetic findings in a 24-year-old male with early childhood onset tremor, seizures ,bradykinesia and  rigidity ,…
  • 2025 International Congress

    Carbidopa/levodopa related hypotension in patients with alpha-synucleinopathies

    D. Rebolledo, JA. Romero-Mera, JC. Lopez-Hernandez, M. Groccopatel-Marra, A. Gonzalez-Duarte, P. Millar Vernetti, H. Kaufmann (New York, USA)

    Objective: Evaluate blood pressure response to levodopa/carbidopa in patients with synucleinopathies undergone to autonomic testing. Background: Carbidopa/levodopa is the mainstay treatment of patients with synucleinopathies,…
  • 2025 International Congress

    Rethinking Parkinsonism: Limitations in Clinical Diagnosis

    S. Lallani, K. Poston (Stanford, USA)

    Objective: To highlight the limitations in clinically differentiating PD and MSA. Background: The antemortem differentiation of parkinsonian syndromes remains challenging due to overlapping symptomatology, particularly…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley